SI2415475T1 - Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum - Google Patents
Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenumInfo
- Publication number
- SI2415475T1 SI2415475T1 SI201030845T SI201030845T SI2415475T1 SI 2415475 T1 SI2415475 T1 SI 2415475T1 SI 201030845 T SI201030845 T SI 201030845T SI 201030845 T SI201030845 T SI 201030845T SI 2415475 T1 SI2415475 T1 SI 2415475T1
- Authority
- SI
- Slovenia
- Prior art keywords
- prebiotic
- duodenum
- stomach
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009111362/15A RU2410100C2 (en) | 2009-03-30 | 2009-03-30 | Pharmaceutical composition of proton pump inhibitor and prebiotic for treating gastric and duodenal ulcers |
PCT/RU2010/000197 WO2010114425A2 (en) | 2009-03-30 | 2010-04-23 | Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
EP10759105.9A EP2415475B1 (en) | 2009-03-30 | 2010-04-23 | Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2415475T1 true SI2415475T1 (en) | 2015-03-31 |
Family
ID=42828898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201030845T SI2415475T1 (en) | 2009-03-30 | 2010-04-23 | Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
Country Status (15)
Country | Link |
---|---|
US (2) | US20120028914A1 (en) |
EP (1) | EP2415475B1 (en) |
CN (1) | CN102333534B (en) |
BR (1) | BRPI1014831A2 (en) |
CY (1) | CY1116050T1 (en) |
DK (1) | DK2415475T3 (en) |
EA (1) | EA022204B1 (en) |
ES (1) | ES2527470T3 (en) |
HR (1) | HRP20150001T1 (en) |
PL (1) | PL2415475T3 (en) |
PT (1) | PT2415475E (en) |
RU (1) | RU2410100C2 (en) |
SI (1) | SI2415475T1 (en) |
UA (1) | UA97078C2 (en) |
WO (1) | WO2010114425A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2449787C1 (en) * | 2011-01-12 | 2012-05-10 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" | Method of treating erosions and ulcers of gastric mucosa |
DE102011013524A1 (en) * | 2011-03-10 | 2012-09-13 | SC "PharmVILAR" CJSC | Gastroprotective agent comprises Exportal, which is 4-O-(beta-galactopyranosyl)-D-glucitomonohydrate) |
RU2501549C1 (en) * | 2012-08-30 | 2013-12-20 | Авва Девелопмент Лтд | Pharmaceutical composition for treating gastroesophageal reflux disease |
CN108159059A (en) * | 2017-12-15 | 2018-06-15 | 哈尔滨珍宝制药有限公司 | A kind of pharmaceutical composition comprising Esomeprazole sodium and preparation method thereof |
CN108904546A (en) * | 2018-07-10 | 2018-11-30 | 山东腾贵医药有限公司 | A kind of pair of helicobacter pylori has inhibition, the probiotic combinations preparation of killing effect and preparation method thereof |
CN111166776A (en) * | 2018-11-10 | 2020-05-19 | 湖南益优健康产业有限公司 | Formula for eradicating chronic gastritis caused by helicobacter pylori |
CN109566951B (en) * | 2018-11-26 | 2021-09-17 | 大兴安岭北天原生物科技有限责任公司 | Stomach-protecting chewable tablet containing radix astragali or stem, leaf and flower of radix astragali |
CN109497557B (en) * | 2019-01-06 | 2022-07-15 | 赵勤农 | Composition for resisting Hp infection and promoting gastric flora balance and application thereof |
CN111903962A (en) * | 2020-05-25 | 2020-11-10 | 上海复旦奥医医学科技有限公司 | Special clinical nutrition formula for gastric ulcer and duodenal ulcer and preparation thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4993893A (en) * | 1992-07-31 | 1994-03-03 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
MX9304638A (en) * | 1992-07-31 | 1994-05-31 | Neose Pharm Inc | COMPOSITION TO TREAT AND INHIBIT GASTRIC AND DUODENAL ULCERS. |
AU6042594A (en) * | 1993-02-26 | 1994-09-14 | Thomas Boren | Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
AU5446798A (en) * | 1996-11-27 | 1998-06-22 | Procter & Gamble Company, The | Compositions and methods for the treatment of gastrointestinal disorders |
US6117868A (en) | 1998-09-16 | 2000-09-12 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
RU2184558C2 (en) * | 2000-08-07 | 2002-07-10 | Нижегородская государственная медицинская академия | Method to treat ulcerous duodenal disease |
FI20011403A (en) * | 2001-06-29 | 2002-12-30 | Carbion Oy | Procedures and compositions for the treatment of gastric diseases |
US6685427B1 (en) * | 2002-07-23 | 2004-02-03 | General Electric Company | Brush seal for a rotary machine and method of retrofitting |
EP1617842A1 (en) * | 2003-04-22 | 2006-01-25 | Dr. Reddy's Laboratories Ltd. | Oral pharmaceutical formulations comprising acid-labile active ingredients and a water-soluble sugar derivate, use thereof and the suitable process for manufacturing these |
US7670624B2 (en) * | 2004-01-29 | 2010-03-02 | Astella Pharma Inc. | Gastrointestinal-specific multiple drug release system |
TW200602089A (en) * | 2004-06-07 | 2006-01-16 | Wyeth Corp | Sugar coatings and methods therefor |
EP2012807A4 (en) * | 2006-04-10 | 2009-07-08 | Dikovskiy Aleksander Vladimiro | Pharmaceutical composition of enterosorbent and prebiotics, dosage forms, and the method for prevention and treatment of gastrointestinal disorders |
RU2325187C1 (en) * | 2006-11-21 | 2008-05-27 | Александр Владимирович Диковский | Pharmaceutical formulation of antibiotics and prebiotics (versions) applied for prevention and medical treatment of disbioses caused by antibacterial therapy |
-
2009
- 2009-03-30 RU RU2009111362/15A patent/RU2410100C2/en not_active IP Right Cessation
-
2010
- 2010-04-23 EP EP10759105.9A patent/EP2415475B1/en not_active Not-in-force
- 2010-04-23 DK DK10759105.9T patent/DK2415475T3/en active
- 2010-04-23 BR BRPI1014831A patent/BRPI1014831A2/en active Search and Examination
- 2010-04-23 EA EA201100857A patent/EA022204B1/en not_active IP Right Cessation
- 2010-04-23 PT PT107591059T patent/PT2415475E/en unknown
- 2010-04-23 ES ES10759105.9T patent/ES2527470T3/en active Active
- 2010-04-23 SI SI201030845T patent/SI2415475T1/en unknown
- 2010-04-23 PL PL10759105T patent/PL2415475T3/en unknown
- 2010-04-23 UA UAA201107579A patent/UA97078C2/en unknown
- 2010-04-23 CN CN2010800074518A patent/CN102333534B/en not_active Expired - Fee Related
- 2010-04-23 WO PCT/RU2010/000197 patent/WO2010114425A2/en active Application Filing
- 2010-04-23 US US13/257,361 patent/US20120028914A1/en not_active Abandoned
-
2015
- 2015-01-01 HR HRP20150001AT patent/HRP20150001T1/en unknown
- 2015-01-07 CY CY20151100010T patent/CY1116050T1/en unknown
-
2016
- 2016-01-28 US US15/008,600 patent/US20160136194A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EA022204B1 (en) | 2015-11-30 |
US20120028914A1 (en) | 2012-02-02 |
DK2415475T3 (en) | 2015-01-12 |
EP2415475B1 (en) | 2014-12-31 |
CY1116050T1 (en) | 2017-01-25 |
UA97078C2 (en) | 2011-12-26 |
RU2410100C2 (en) | 2011-01-27 |
PL2415475T3 (en) | 2015-03-31 |
EA201100857A1 (en) | 2011-12-30 |
CN102333534A (en) | 2012-01-25 |
RU2009111362A (en) | 2010-10-10 |
EP2415475A2 (en) | 2012-02-08 |
PT2415475E (en) | 2015-01-13 |
CN102333534B (en) | 2013-01-02 |
BRPI1014831A2 (en) | 2016-04-12 |
HRP20150001T1 (en) | 2015-02-27 |
WO2010114425A2 (en) | 2010-10-07 |
ES2527470T3 (en) | 2015-01-26 |
US20160136194A1 (en) | 2016-05-19 |
EP2415475A4 (en) | 2012-09-05 |
WO2010114425A8 (en) | 2011-12-08 |
WO2010114425A3 (en) | 2011-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2415475T3 (en) | Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum | |
IL246714A (en) | Systems for increasing the diffusion of a pharmaceutical composition in a body lumen | |
IL205548A0 (en) | Compositions for the treatment of inflammation of the gastrointestinal tract | |
EP2118074A4 (en) | Compounds for the prevention and treatment of cardiovascular diseases | |
HK1144390A1 (en) | Compositions for the treatment of neoplastic diseases | |
EP1962839A4 (en) | Administration of mntor inhibitor to treat patients with cancer | |
EP2493497A4 (en) | Notch inhibition in the treatment and prevention of obesity and metabolic syndrome | |
SI2139483T1 (en) | Combination therapies comprising a quinoxaline inhibitor of pi3k-alpha for use in the treatment of cancer | |
EP2155197A4 (en) | Treatment of lysosomal storage diseases | |
EP3868323C0 (en) | Minimally invasive devices for the treatment of prostate diseases | |
EP2440209A4 (en) | Compositions and methods for the prevention and treatment of heart failure | |
HK1134450A1 (en) | Treatment of virally induced lesions | |
BRPI0917444A2 (en) | gastric retention pharmaceutical compositions for the treatment and prevention of snc diseases | |
HK1191861A1 (en) | Fast acting inhibitor of gastric acid secretion | |
IL224215A (en) | Combination pharmaceutical composition for treating functional diseases or conditions of the gastrointestinal tract | |
IL217198A0 (en) | Composition for treating a patient in need of aspirin therapy | |
IL186374A (en) | Combined use of prostaglandin compound and proton pump inhibitor for manufacture of a pharmaceutical composition for the treatment of gastrointestinal disorders and a pharmaceutical composition comprising them | |
HK1171677A1 (en) | Composition for the treatment of hemorrhoids and related diseases | |
IL196667A (en) | Use of peptides for the manufacture of a medicament for treating inflammation | |
EP2015741A4 (en) | Histone deacetylase inhibitors for the treatment of neurodegeneration | |
IL213711A (en) | Pharmaceutical formulation of nanonised fenofibrate | |
IL217143A (en) | Pharmaceutical compositions comprising a manganese complex compound and a non-manganese complex form of the compound and uses thereof in preparing medicaments for treating pathological conditions | |
EP2194936A4 (en) | Medical bandaging product | |
EP2157089A4 (en) | The therapeutic uses of imidazol-5-carboxylic acid derivatives | |
HK1185345A1 (en) | Compounds for the prevention and treatment of cardiovascular diseases |